Structure Therapeutics, Inc. (GPCR)
22.88
+0.87
(+3.95%)
USD |
NASDAQ |
Oct 20, 16:00
23.05
+0.17
(+0.74%)
After-Hours: 07:08
Structure Therapeutics Gross Profit (TTM) : -4.876M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.876M |
| March 31, 2026 | -4.432M |
| December 31, 2025 | -3.900M |
| September 30, 2025 | -4.391M |
| June 30, 2025 | -3.680M |
| March 31, 2025 | -3.057M |
| December 31, 2024 | -3.029M |
| September 30, 2024 | -1.439M |
| June 30, 2024 | -1.523M |
| Date | Value |
|---|---|
| March 31, 2024 | -1.451M |
| December 31, 2023 | -0.9459M |
| September 30, 2023 | -0.8127M |
| June 30, 2023 | -0.6159M |
| March 31, 2023 | -0.6079M |
| December 31, 2022 | -0.5854M |
| June 30, 2022 | -0.4377M |
| March 31, 2022 | -0.2835M |
| December 31, 2021 | -0.1313M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Eli Lilly & Co. | 66.44B |
| Novo Nordisk A/S | 41.49B |
| Pfizer Inc. | 41.30B |
| Viking Therapeutics, Inc. | -0.45M |
| Liquidia Corp. | 416.18M |